THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE
Thorir D. Bjornsson(Pfizer (United States)), John T. Callaghan, Heidi J. Einolf(Novartis (China)), Volker Fischer(Novartis (China)), Lawrence L. Gan(Takeda (Japan)), Scott Grimm(AstraZeneca (Brazil)), John Y. Kao(Pfizer (United States)), Shang‐Ying P. King, Gerald T. Miwa(Takeda (Japan)), Lan Ni, Gondi Kumar, James F. McLeod(Novartis (China)), R. Scott Obach(Pfizer (United States)), Stanley Roberts(Abbott (United Kingdom)), Amy L. Roe(Procter & Gamble (United States)), Anita Shah(Bayer (Germany)), Fred Snikeris(Sanofi (Mexico)), John T. Sullivan, Donald Tweedie, José M. Vega, John Walsh(GlaxoSmithKline (Netherlands)), Steven Wrighton
Cited by 784
Abstract
Related Papers
No related papers found
Powered by citation graph analysis